Valuation: Medico Remedies Limited

Market Cap 1.55B 16.3M 14.6M 13.43M 12.17M 22.74M 23.17M 160M 64.28M 814M 61.17M 59.87M 2.57B P/E 2025
42.8x
P/E 2026 20.7x
Enterprise Value 1.7B 17.93M 16.06M 14.77M 13.39M 25.02M 25.49M 176M 70.73M 896M 67.31M 65.88M 2.82B EV / Sales 2025
2.94x
EV / Sales 2026 1.39x
Free-Float
31.79%
Yield 2025 *
-
Yield 2026 -
1 day-1.84%
1 week-7.54%
1 month-13.58%
3 months-61.44%
6 months-56.12%
Current year-63.11%
1 week 18.24
Extreme 18.24
20.99
1 month 18.24
Extreme 18.24
23.9
Current year 18.24
Extreme 18.24
56.99
1 year 18.24
Extreme 18.24
56.99
3 years 18.24
Extreme 18.24
92.87
5 years 15.11
Extreme 15.11
100.79
10 years 3.35
Extreme 3.35
100.79
Manager TitleAgeSince
Chief Executive Officer 41 2017-09-14
Director of Finance/CFO 71 2017-09-14
Compliance Officer - 2026-02-17
Director TitleAgeSince
Chairman 71 1994-03-17
Director/Board Member 41 2011-12-13
Director/Board Member 66 2017-09-14
Date Insider Type Main position Quantity % Market Cap. Importance
12/5/24 Sell

Director

1,400,000 1.6871%
12/5/24 Sell

Director

400,000 0.4820%
11/20/24 Sell

General Counsel

900,000 1.0845%
Change 5-day change 1-year change 3-year change Capi.($)
-1.84%-7.54%-63.07%-75.13% 16.3M
+3.19%+11.31%+64.28%+155.91% 1,263B
-0.73%+3.56%+44.65%+84.17% 658B
+1.41%+3.24%+35.25%+108.88% 521B
+0.42%+3.20%+55.81%+72.50% 391B
+2.18%+2.93%+73.90%+45.59% 369B
+1.12%+4.52%+34.76%+58.24% 307B
+6.96%+8.86%+11.95%+36.20% 290B
+1.15%+6.09%+56.15%+82.25% 252B
+3.06%+9.38%+42.48%+117.32% 212B
Average +1.69%+4.56%+35.62%+68.59% 426.19B
Weighted average by Cap. +2.01%+6.60%+50.51%+100.44%

Financials

2025 2026
Net sales 1.51B 15.9M 14.24M 13.1M 11.87M 22.18M 22.6M 156M 62.69M 794M 59.66M 58.39M 2.5B 2.06B 21.74M 19.47M 17.91M 16.22M 30.33M 30.89M 214M 85.72M 1.09B 81.57M 79.84M 3.42B
Net income 101M 1.06M 952K 876K 793K 1.48M 1.51M 10.44M 4.19M 53.09M 3.99M 3.9M 167M 131M 1.38M 1.24M 1.14M 1.03M 1.93M 1.96M 13.57M 5.45M 68.99M 5.18M 5.07M 218M
Net Debt 122M 1.28M 1.15M 1.05M 955K 1.79M 1.82M 12.58M 5.05M 63.93M 4.8M 4.7M 202M 155M 1.64M 1.46M 1.35M 1.22M 2.28M 2.32M 16.06M 6.45M 81.67M 6.14M 6.01M 258M
Projected Income Statement - Annual - Medico Remedies Limited
Logo Medico Remedies Limited
Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The Company also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.
Employees
105
Date Price Change Volume
26-10-30 ₹18.65 -1.84% 6,846
26-10-29 ₹19.00 -2.11% 26,120
26-10-28 ₹19.41 -4.38% 18,708
26-10-27 ₹20.30 +1.20% 3,768
26-10-26 ₹20.06 -0.55% 8,499
  1. Stock Market
  2. Stocks
  3. MEDICO Stock